Academic Content and Language Evaluation of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (9245)
All Articles published online
|
Publishing Process of This Article
|
Mar 28, 2014 (publication date) through Apr 16, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Nakazawa T, Naitoh I, Hayashi K, Sano H, Miyabe K, Shimizu S, Joh T. Inflammatory bowel disease of primary sclerosing cholangitis: A distinct entity? World J Gastroenterol 2014; 20(12): 3245-3254 [PMID: 24696608 DOI: 10.3748/wjg.v20.i12.3245] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v20/i12/3245.htm |
| Number | Citing Articles |
| 1 |
|
| 2 |
Bence Kővári, Rish K. Pai. Upper Gastrointestinal Tract Involvement in Inflammatory Bowel Diseases: Histologic Clues and Pitfalls. Advances in Anatomic Pathology 2022; 29(1): 2 doi: 10.1097/PAP.0000000000000311
|
| 3 |
Henrique C. Rocha, Eduardo G. Vilela. Clinical aspects and prognosis of patients with inflammatory bowel disease associated with autoimmune liver diseases. Gastroenterología y Hepatología (English Edition) 2022; 45(2): 83 doi: 10.1016/j.gastre.2021.03.011
|
| 4 |
Carolina Palmela, Farhad Peerani, Daniel Castaneda, Joana Torres, Steven H. Itzkowitz. Inflammatory Bowel Disease and Primary Sclerosing Cholangitis: A Review of the Phenotype and Associated Specific Features. Gut and Liver 2018; 12(1): 17 doi: 10.5009/gnl16510
|
| 5 |
Dustin E. Bosch, Matthew M. Yeh. Primary sclerosing cholangitis is protective against nonalcoholic fatty liver disease in inflammatory bowel disease. Human Pathology 2017; 69: 55 doi: 10.1016/j.humpath.2017.09.008
|
| 6 |
Kourosh M. Shirazi, Yasaman Hosseinzadeh, Zahra Nourpanah, Arman M. Shirazinezhad, Zeinab Nikniaz. The value of serum CA19‐9 in predicting primary sclerosing cholangitis in patients with ulcerative colitis. Advances in Digestive Medicine 2020; 7(3): 147 doi: 10.1002/aid2.13155
|
| 7 |
Natália de Carvalho Trevizoli, Evelyn Jacome Obeid, Silas Gustavo Barboza Romeres, Carolina Augusta Matos de Oliveira, Henrique Carvalho Rocha, Daniela Mariano Carvalho-Louro, Gustavo de Sousa Arantes Ferreira, Priscila Brizolla De Campos, Raquel Francine Bundchen Ullmann, Ana Virgínia Ferreira Figueira, Luiz Gustavo Guedes Diaz, Fernando Marcus Felippe Jorge, Gabriel Oliveira Nunes Caja, Zuleica Barrio Bortoli, André Luis Conde Watanabe. Liver Transplant and Active Ulcerative Colitis: A Case Report. Transplantation Proceedings 2022; 54(5): 1361 doi: 10.1016/j.transproceed.2022.03.041
|
| 8 |
Hwajeong Lee, Maria Westerhoff, Bo Shen, Xiuli Liu. Clinical Aspects of Idiopathic Inflammatory Bowel Disease: A Review for Pathologists. Archives of Pathology & Laboratory Medicine 2016; 140(5): 413 doi: 10.5858/arpa.2015-0305-RA
|
| 9 |
A. V. Nikitin, G. V. Volynets. Sclerosing cholangitis and inflammatory bowel disease: which comes first?. Rossiyskiy Vestnik Perinatologii i Pediatrii (Russian Bulletin of Perinatology and Pediatrics) 2021; 66(1): 39 doi: 10.21508/1027-4065-2021-66-1-39-46
|
| 10 |
Juliana Silva, Beatriz S. Brito, Isaac Neri de N. Silva, Viviane G. Nóbrega, Maria Carolina S. M. da Silva, Hemerson Dyego de N. Gomes, Flora Maria Fortes, Andrea M. Pimentel, Jaciane Mota, Neogélia Almeida, Valdiana C. Surlo, André Lyra, Raquel Rocha, Genoile O. Santana. Frequency of Hepatobiliary Manifestations and Concomitant Liver Disease in Inflammatory Bowel Disease Patients. BioMed Research International 2019; 2019: 1 doi: 10.1155/2019/7604939
|
| 11 |
Martin Cornillet, Christina Villard, Fredrik Rorsman, Antonio Molinaro, Emma Nilsson, Stergios Kechagias, Erik von Seth, Annika Bergquist. The Swedish initiative for the study of Primary sclerosing cholangitis (SUPRIM). eClinicalMedicine 2024; 70: 102526 doi: 10.1016/j.eclinm.2024.102526
|
| 12 |
Asad Ur Rahman, Faisal Inayat, Saeed Ali, Effa Zahid, Roger Charles. The role of oral vancomycin in inducing remission for biologic-experienced ulcerative colitis with concomitant primary sclerosing cholangitis and liver transplantation. Clinical Journal of Gastroenterology 2021; 14(1): 159 doi: 10.1007/s12328-020-01272-8
|
| 13 |
Ryan B. O’Malley, Neil J. Hansen, Jonathan Carnell, Anita Afzali, Mariam Moshiri. Update on MR Enterography: Potentials and Pitfalls. Current Radiology Reports 2016; 4(8) doi: 10.1007/s40134-016-0172-x
|
| 14 |
|
| 15 |
Agnes Wittek, Babett Steglich, Christian Casar, Oliver Seiz, Philipp Huber, Hanno Ehlken, Dominik Reher, Sandra Wende, Tanja Bedke, Jan Kempski, Marius Böttcher, Corinna Bang, Louise Thingholm, Till Krech, Ansgar W Lohse, Guido Sauter, Thomas Rösch, Andre Franke, Christoph Schramm, Nicola Gagliani, Penelope Pelczar, Samuel Huber. A Gradient of Intestinal Inflammation in Primary Sclerosing Cholangitis. Inflammatory Bowel Diseases 2023; doi: 10.1093/ibd/izad137
|
| 16 |
Maud A. Reijntjes, Lianne Heuthorst, Krisztina Gecse, Aart Mookhoek, Willem A. Bemelman, Christianne J. Buskens. Clinical relevance of endoscopic peri-appendiceal red patch in ulcerative colitis patients. Therapeutic Advances in Gastroenterology 2022; 15: 175628482210988 doi: 10.1177/17562848221098849
|
| 17 |
Christopher M Nguyen, Kevin T Kline, Heather L Stevenson, Kashif Khan, Sreeram Parupudi. Small duct primary sclerosing cholangitis: A discrete variant or a bridge to large duct disease, a practical review. World Journal of Hepatology 2022; 14(3): 495-503 doi: 10.4254/wjh.v14.i3.495
|
| 18 |
Hiroyuki Isayama, Susumu Tazuma, Norihiro Kokudo, Atsushi Tanaka, Toshio Tsuyuguchi, Takahiro Nakazawa, Kenji Notohara, Suguru Mizuno, Nobuhisa Akamatsu, Masahiro Serikawa, Itaru Naitoh, Yoshiki Hirooka, Toshifumi Wakai, Takao Itoi, Tomoki Ebata, Shinji Okaniwa, Terumi Kamisawa, Hiroki Kawashima, Atsushi Kanno, Keiichi Kubota, Masami Tabata, Michiaki Unno, Hajime Takikawa. Clinical guidelines for primary sclerosing cholangitis 2017. Journal of Gastroenterology 2018; 53(9): 1006 doi: 10.1007/s00535-018-1484-9
|
| 19 |
Vittorio Branchi, Tobias J. Weismüller, Taotao Zhou, Jonas Henn, Alexander Semaan, Tim R. Glowka, Maria Gonzalez-Carmona, Christian Strassburg, Jörg C. Kalff, Steffen Manekeller, Hanno Matthaei. Chirurgische Therapie der primär sklerosierenden Cholangitis. Der Chirurg 2021; 92(2): 148 doi: 10.1007/s00104-020-01197-5
|
| 20 |
Rui Gaspar, Catarina Castelo Branco, Guilherme Macedo. Liver manifestations and complications in inflammatory bowel disease: A review. World Journal of Hepatology 2021; 13(12): 1956-1967 doi: 10.4254/wjh.v13.i12.1956
|
| 21 |
Guillaume Pineton de Chambrun, Maria Nachury, Natalie Funakoshi, Romain Gerard, Michael Bismuth, Jean-Christophe Valats, Fabrizio Panaro, Francis Navarro, Pierre Desreumaux, Benjamin Pariente, Pierre Blanc. Oral vancomycin induces sustained deep remission in adult patients with ulcerative colitis and primary sclerosing cholangitis. European Journal of Gastroenterology & Hepatology 2018; 30(10): 1247 doi: 10.1097/MEG.0000000000001223
|
| 22 |
Hiep Nguyen Canh, Kenichi Harada. Adult bile duct strictures: differentiating benign biliary stenosis from cholangiocarcinoma. Medical Molecular Morphology 2016; 49(4): 189 doi: 10.1007/s00795-016-0143-6
|
| 23 |
Takahiro Nakazawa, Kenji Notohara, Susumu Tazuma, Atsushi Tanaka, Hiroyuki Isayama, Toshio Tsuyuguchi, Toshiyuki Mori, Hajime Takikawa. The 2016 diagnostic criteria for primary sclerosing cholangitis. Journal of Gastroenterology 2017; 52(7): 838 doi: 10.1007/s00535-016-1286-x
|
| 24 |
Henrique C. Rocha, Eduardo G. Vilela. Clinical aspects and prognosis of patients with inflammatory bowel disease associated with autoimmune liver diseases. Gastroenterología y Hepatología 2022; 45(2): 83 doi: 10.1016/j.gastrohep.2021.03.011
|
| 25 |
Olga V. Usoltseva, Andrey N. Surkov, Goar B. Movsisyan, Elena A. Kulebina, Svetlana A. Simersina, Alexander S. Potapov, Maksim M. Lokhmatov. Primary sclerosing cholangitis in children with inflammatory bowel disease. Russian Pediatric Journal 2022; 24(6): 395 doi: 10.46563/1560-9561-2021-24-6-395-404
|
| 26 |
Shuichiro Umetsu, Kenji Notohara, Takahiro Nakazawa, Tomoyuki Tsunoda, Tsuyoshi Sogo, Haruki Komatsu, Atsushi Tanaka, Susumu Tazuma, Hajime Takikawa, Ayano Inui, Tomoo Fujisawa. Long‐term outcomes of pediatric‐onset primary sclerosing cholangitis: A single‐center experience in Japan. Hepatology Research 2019; 49(12): 1386 doi: 10.1111/hepr.13421
|